Lincoln Pharmaceuticals informs about clarification

30 Apr 2021 Evaluate

Lincoln Pharmaceuticals has clarified that the company has made timely disclosures of all the events and information which fall under the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and which otherwise would be necessary for investors to know for making sound investment decision. The Company hereby confirmed that there are no other major events which have occurred or likely to occur in near future which, can have major bearing on the operations/ performance of the Company or Company’s working or financial positions including all price sensitive information of the scrip. If any of such event will occur then the Company will immediately intimate the same to the exchanges in due compliance of relevant regulations.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

617.50 -0.15 (-0.02%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.